Overexpression of activated nuclear factor-κ B in aorta of patients with coronary atherosclerosis

Clinical Cardiology

Volumn 32, Issue 12, 2009, Pages

  Zhang, Wei ^a   Xing, Shan Shan ^a,b   Sun, Xue Lin ^b   Xing, Qi Chong ^a,b  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b SHANDONG UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

HIGH DENSITY LIPOPROTEIN CHOLESTEROL; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; LIPOPROTEIN A; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ARTICLE; ASCENDING AORTA; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; CORONARY ARTERY ATHEROSCLEROSIS; CORONARY ARTERY BYPASS GRAFT; CORRELATION COEFFICIENT; DISEASE SEVERITY; GEL MOBILITY SHIFT ASSAY; GENE OVEREXPRESSION; GLUCOSE BLOOD LEVEL; HUMAN; HUMAN TISSUE; HYPERTENSION; IMMUNOHISTOCHEMISTRY; INFLAMMATION; RISK FACTOR; SMOKING; TRANSCRIPTION INITIATION;

AGED; AORTA; BLOOD GLUCOSE; CHOLESTEROL; CHOLESTEROL, LDL; CORONARY ARTERY BYPASS; CORONARY ARTERY DISEASE; FEMALE; HUMANS; HYPERTENSION; IMMUNOHISTOCHEMISTRY; LIPOPROTEIN(A); MALE; MIDDLE AGED; NF-KAPPA B; SEVERITY OF ILLNESS INDEX; SMOKING;

EID: 74849102423     PISSN: 01609289     EISSN: 19328737     Source Type: Journal    
DOI: 10.1002/clc.20482     Document Type: Article

References (23)

1. Ross R. Atherosclerosis - an inflammatory disease. N Engl J Med. 1999; 340(2):115-126.
2. de Winther MP, Kanters E, Kraal G, Hofker MH. Nuclear factor kappaB signaling in atherogenesis. Arterioscler Thromb Vasc Biol. 2005; 25(5):904-914.
3. World Medical Association declaration of Helsinki: Recommendations guiding physicians in biomedical research involving human subjects. JAMA. 1997;277(11):925-926.
4. Gensini GG. A more meaningful scoring system for determining the severity of coronary heart disease. Am J Cardiol. 1983;51(3): 606.
5. Wilson SH, Best PJ, Edwards WD, et al Nuclear factor-kappa B immunoreactivity is present in human coronary plaque and enhanced in patients with unstable angina pectoris. Atherosclerosis. 2002;160(1):147-153.
6. Kranzhöfer R, Schmidt J, Pfeiffer CA, Hagl S, Libby P, Kübler W. Angiotensin induces inflammatory activation of human vascular smooth muscle cells. Arterioscler Thromb Vasc Biol. 1999;19(7):1623-1629.
7. Baeuerle PA, Henkel T. Function and activation of NF-kappa B in the immune system. Annu Rev Immunol. 1994;12:141-179.
8. Stoll G, Bendszus M. Inflammation and atherosclerosis: novel insights into plaque formation and destabilization. Stroke. 2006; 37(7):1923-1932.
9. Kastl SP, Speidl WS, Kaun C, et al The complement component C5a induces the expression of plasminogen activator inhibitor-1 in humanmacrophages via NF-kappaB activation. J Thromb Haemost. 2006;4(8):1790-1797.
10. Collins T. Endothelial nuclear factor-kappaB and the initiation of the atherosclerotic lesion. Lab Invest. 1993;68(5):499-508.
11. Viedt C, Hansch GM, Brandes RP, Kubler W, Kreuzer J. The terminal complement complex C5b-9 stimulates interleukin-6 production in human smooth muscle cells through activation of transcription factors NF-kappaB and AP-1. FASEB J. 2000;14(15): 2370-2372.
12. Ginn-Pease ME, Whisler RL. Redox signals and NF-kappaB activation in T cells. Free Radic Biol Med. 1998;25(3):346-361.
13. Strong JP. Atherosclerotic lesions. Natural history, risk factors, and topography. Arch Pathol Lab Med. 1992;116(12):1268-1275.
14. Frangos SG, Gahtan V, Sumpio B. Localization of atherosclerosis: role of hemodynamics. Arch Surg. 1999;134(10):1142-1149.
15. Brand K, Page S, Rogler G, et al Activated transcription factor nuclear factor-kappaB is present in the atherosclerotic lesion. J Clin Invest. 1996;97(7):1715-1722.
16. Zhang S, Day IN, Ye S. Microarray analysis of nicotine-induced changes in gene expression in endothelial cells. Physiol Genomics. 2001;5(4):187-192.
17. Browatzki M, Larsen D, Pfeiffer CA, Gehrke SG, Schmidt J. Angiotensin II stimulates matrix metalloproteinase secretion in human vascular smooth muscle cells via nuclear factor-kappa B and activator protein 1 in a redox-sensitive manner. J Vasc Res. 2005;42(5):415-423.
18. Schwartz EA, Reaven PD. Molecular and signaling mechanisms of atherosclerosis in insulin resistance. Endocrinol Metab Clin North Am. 2006;35(3):525-549, viii.
19. Cominacini L, Anselmi M, Garbin U, Fratta Pasini A, Stranieri C. Enhanced plasma levels of oxidized low-density lipoprotein increase circulating nuclear factor-kappaB activation in patients with unstable angina. J Am Coll Cardiol. 2005;46(5):799-806.
20. Oitzinger W, Hofer-Warbinek R, Schmid JA, Koshelnick Y, Binder BR, de Martin R. Adenovirus-mediated expression of a mutant IkappaB kinase 2 inhibits the response of endothelial cells to inflammatory stimuli. Blood. 2001;97(6):1611-1617.
21. Ping D, Boekhoudt GH, Rogers EM, Boss JM. Nuclear factor-kappa B p65 mediates the assembly and activation of the TNF-responsive element of the murine monocyte chemoattractant-1 gene. J Immunol. 1999;162(2):727-734.
22. Bäck M, Bu DX, Bränstrüm R, Sheikine Y, Yan ZQ, Hansson GK. Leukotriene B4 signaling through NF-κB-dependent BLT1 receptors on vascular smoothmuscle cells in atherosclerosis and intimal hyperplasia. Proc Natl Acad Sci USA. 2005;102(48):17501-17506.
23. Fazio GP, Redberg RF, Winslow T, Schiller NB. Transesophageal echocardiographically detected atherosclerotic aortic plaque is a marker for coronary artery disease. J Am Coll Cardiol. 1993;21(1): 144-150.